<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="tubb4a-leuk" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">tubb4a-leuk</book-part-id>
      <title-group>
        <title><italic toggle="yes">TUBB4A</italic>-Related Leukodystrophy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nahhas</surname>
            <given-names>Norah</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Children&#x02019;s National Health System<break/>Washington, DC</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Conant</surname>
            <given-names>Alex</given-names>
          </name>
          <degrees>BS</degrees>
          <aff>Children&#x02019;s National Health System<break/>Washington, DC</aff>
          <email>aconant@childrensnational.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hamilton</surname>
            <given-names>Eline</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>VU University Medical Center<break/>Amsterdam, Netherlands</aff>
          <email>e.hamilton@vumc.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Curiel</surname>
            <given-names>Julian</given-names>
          </name>
          <degrees>BS</degrees>
          <aff>Children&#x02019;s National Health System<break/>Washington, DC</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Simons</surname>
            <given-names>Cas</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Institute for Molecular Bioscience<break/>University of Queensland<break/>Brisbane, Australia</aff>
          <email>c.simons@imb.uq.edu.au</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van der Knaap</surname>
            <given-names>Marjo</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>VU University Medical Center<break/>Amsterdam, Netherlands</aff>
          <email>ms.vanderknaap@vumc.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vanderver</surname>
            <given-names>Adeline</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Children&#x02019;s Hospital of Philadelphia<break/>Philadelphia, Pennsylvania</aff>
          <email>vandervera@email.chop.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>3</day>
          <month>11</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="pc-hypo-p" document-type="chapter">
<italic toggle="yes">TSEN54</italic>-Related Pontocerebellar Hypoplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="tetra-amelia" document-type="chapter">Tetra-Amelia Syndrome</related-object>
      <abstract id="tubb4a-leuk.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">TUBB4A</italic>-related leukodystrophy comprises a phenotypic spectrum in which the MRI findings range from hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) at the severe end to isolated hypomyelination at the mild end. Progressive neurologic findings reflect involvement of the pyramidal tracts (spasticity, brisk deep tendon reflexes, and Babinski sign), extrapyramidal system (rigidity, dystonia, choreoathetosis, oculogyric crisis, and perioral dyskinesia), cerebellum (ataxia, intention tremor, dysmetria), and bulbar function (dysarthria, dysphonia, and swallowing). Cognition is variably affected and usually less severely than motor function. Typically, those with H-ABC present in early childhood (ages one to three years) and those with isolated hypomyelination in later childhood or adulthood. The rate of progression varies with disease severity.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is established in a proband with characteristic clinical and MRI findings and a heterozygous <italic toggle="yes">TUBB4A</italic> pathogenic variant identified by molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Functionally disabling spasticity requires medical management and physical therapy; dystonia requires medical management and &#x02013; when refreactory to medical management &#x02013; possibly surgical intervention. Swallowing dysfunction may require use of a gastrostomy for feeding. Seizures, constipation, and gastroesophageal reflux disease are treated in the routine manner.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Calcium and vitamin D supplementation as required to prevent osteoporosis; attention to skin care and frequent repositioning help prevent pressure sores in individuals with decreased mobility; annual flu vaccination; use of routine fall prevention strategies, adaptive equipment (e.g., wheelchairs and walkers), and physical therapy to help prevent secondary injury.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine evaluations of (1) swallowing and feeding to reduce the risk of aspiration; (2) nutrition to prevent malnutrition; (3) orthopedic and joint integrity to detect joint dislocation and scoliosis. At least yearly: (1) medical evaluations to assess weight and medications; (2) evaluations by specialists in occupational therapy, physical therapy, speech therapy, rehabilitation medicine. Annual neurologic assessment to detect emerging complications.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">TUBB4A</italic>-related leukodystrophy is inherited in an autosomal dominant manner. Most affected individuals have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The risk to sibs of a proband with clinically unaffected parents is low but greater than that of the general population because of the possibility of germline mosaicism or somatic and germline mosaicism in a parent. Individuals with <italic toggle="yes">TUBB4A</italic>-related leukodystrophy are not known to reproduce.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="tubb4a-leuk.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="tubb4a-leuk.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_tubb4a-leuk.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">TUBB4A</italic>-Related Leukodystrophy: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_tubb4a-leuk.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC)</p>
                    </list-item>
                    <list-item>
                      <p>Isolated hypomyelination</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tubb4a-leuk.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes, see <xref ref-type="sec" rid="tubb4a-leuk.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="tubb4a-leuk.Diagnosis">
        <title>Diagnosis</title>
        <sec id="tubb4a-leuk.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">TUBB4A</italic>-related leukodystrophy <bold>should be suspected</bold> in individuals with the following clinical and brain MRI findings that define the two hypomyelination phenotypes:</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Onset during infancy or childhood</p>
            </list-item>
            <list-item>
              <p>Motor developmental delay</p>
            </list-item>
            <list-item>
              <p>Presence of pyramidal and extrapyramidal signs</p>
            </list-item>
            <list-item>
              <p>Gait ataxia and cerebellar dysfunction</p>
            </list-item>
            <list-item>
              <p>Dysarthria, aphonia, or &#x0201c;whispering&#x0201d; dysphonia</p>
            </list-item>
          </list>
          <p>
            <bold>Brain MRI findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC)</bold> [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_der_knaap.2002.1466">van der Knaap et al 2002</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.sasaki.2009.582">Sasaki et al 2009</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.blumkin.2014.107">Blumkin et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.ferreira.2014.1802">Ferreira et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.hamilton.2014.1921">Hamilton et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.sagnelli.2016.591">Sagnelli et al 2016</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.tonduti.2016.323">Tonduti et al 2016</xref>] is characterized by (<xref ref-type="fig" rid="tubb4a-leuk.F1">Figure 1</xref>):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Progressive atrophy of the basal ganglia involving the neostriatum (i.e., the putamen and caudate nucleus) predominantly, often with a significant decrease in size of the putamen (which can disappear over time) and to a lesser degree the head of the caudate. The thalamus and globus pallidus are typically spared. Note that although changes in the putamen are evident in many children with the H-ABC phenotype by age two years, in some children the changes may not be evident until later childhood.</p>
                </list-item>
                <list-item>
                  <p>Diffuse cerebral hypomyelination manifest as mild T<sub>2</sub>-weighted hyperintensity involving the supratentorial white matter, corpus callosum, and internal capsule, and typically isointense or mildly hyperintense T<sub>1</sub>-weighted signal</p>
                </list-item>
                <list-item>
                  <p>Cerebellar findings of white matter T<sub>1</sub>-weighted signal that is isointense or mildly hyper- or hypointense relative to gray matter structures. Although cerebellar atrophy prominently affecting the vermis is a common but not obligatory feature of H-ABC.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">TUBB4A</italic>-related isolated hypomyelination</bold> is characterized by variable cerebellar involvement and no evident neostriatal involvement [<xref ref-type="bibr" rid="tubb4a-leuk.REF.pizzino.2014.898">Pizzino et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.purnell.2014.608">Purnell et al 2014</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="tubb4a-leuk.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">TUBB4A</italic>-related leukodystrophy <bold>is established</bold> in a proband with characteristic clinical and MRI findings and a heterozygous <italic toggle="yes">TUBB4A</italic> pathogenic variant identified by molecular genetic testing (see <xref ref-type="table" rid="tubb4a-leuk.T.molecular_genetic_testing">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (multi-gene panel or single-gene testing) and <bold>genomic testing</bold> (comprehensive genomic sequencing) depending on the phenotype.</p>
          <p>Gene-targeted testing requires the clinician to determine which gene(s) are likely involved, whereas genomic testing may not. Because the phenotype of <italic toggle="yes">TUBB4A</italic>-related leukodystrophy is broad, children with the distinctive findings described in <xref ref-type="sec" rid="tubb4a-leuk.Suggestive_Findings">Suggestive Findings</xref> are likely to be diagnosed using gene-targeted testing (see <xref ref-type="sec" rid="tubb4a-leuk.Option_1_GeneTargeted_Testin">Option 1</xref>), whereas those with a mild phenotype indistinguishable from many other inherited hypomyelinating leukodystrophies are more likely to be diagnosed using genomic testing (see <xref ref-type="sec" rid="tubb4a-leuk.Option_2_Genomic_Testing">Option 2</xref>).</p>
          <sec id="tubb4a-leuk.Option_1_GeneTargeted_Testin">
            <title>Option 1. Gene-Targeted Testing</title>
            <p>When the phenotypic findings, such as hypomyelination with basal ganglia atrophy, suggest the diagnosis of <italic toggle="yes">TUBB4A</italic>-related leukodystrophy, molecular genetic testing approaches can include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Recommended: single-gene testing.</bold> Sequence analysis of <italic toggle="yes">TUBB4A</italic> is performed first. If only one pathogenic variant is found, gene-targeted deletion/duplication analysis could be considered; however, to date no exon or whole-gene deletions have been reported.</p>
              </list-item>
              <list-item>
                <p><bold>To consider: multi-gene panel.</bold> A multi-gene leukodystrophy panel that includes <italic toggle="yes">TUBB4A</italic> and other genes of interest (see <xref ref-type="sec" rid="tubb4a-leuk.Differential_Diagnosis">Differential Diagnosis</xref>) may be considered; however, the diagnostic sensitivity of a multi-gene panel may be low in this instance because primary neuronal disorders with MRI findings that resemble a classic leukodystrophy (like <italic toggle="yes">TUBB4A</italic>-related leukodystrophy) are often not included in leukodystrophy panels.)</p>
              </list-item>
            </list>
          </sec>
          <sec id="tubb4a-leuk.Option_2_Genomic_Testing">
            <title>Option 2. Genomic Testing</title>
            <p>When the phenotype is indistinguishable from many other inherited disorders with leukodystrophy or with atypical white matter changes on MRI, the following molecular genetic testing approach is recommended:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Comprehensive genomic sequencing</bold> (when available) including whole-exome sequencing (WES) and whole-genome sequencing (WGS) may be considered if the phenotype alone is insufficient to support gene-targeted testing. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
              </list-item>
            </list>
            <table-wrap id="tubb4a-leuk.T.molecular_genetic_testing" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in <italic toggle="yes">TUBB4A</italic>-Related Leukodystrophy</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">TUBB4A</italic>
                    </td>
                    <td headers="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">71/71 affected individuals</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted duplication/deletion analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_tubb4a-leuk.T.molecular_genetic_testing_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="tubb4a-leuk.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="tubb4a-leuk" object-id="tubb4a-leuk.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="tubb4a-leuk.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="tubb4a-leuk.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="tubb4a-leuk.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="tubb4a-leuk.TF.1.4">
                  <label>4. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="tubb4a-leuk.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="tubb4a-leuk.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">TUBB4A</italic>-related leukodystrophy typically presents between ages one and three years; onset range is a few months of age in more severe forms [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_der_knaap.2002.1466">van der Knaap et al 2002</xref>] to later childhood or adulthood in some instances of isolated hypomyelination [<xref ref-type="bibr" rid="tubb4a-leuk.REF.hamilton.2014.1921">Hamilton et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.pizzino.2014.898">Pizzino et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.shimojima.2015.281">Shimojima et al 2015</xref>].</p>
          <p>The disorder is progressive; rate of progression varies with disease severity. Males and females are similarly affected.</p>
          <p>Manifestations can include the following.</p>
          <p><bold>Delayed motor development.</bold> Some children have a period of normal motor development with subsequent deterioration [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_der_knaap.2002.1466">van der Knaap et al 2002</xref>].</p>
          <p><bold>Cognitive dysfunction.</bold> Cognition is variably affected but usually less severely than motor function. Learning difficulty is common; social awareness is usually preserved.</p>
          <p><bold>Pyramidal involvement.</bold> Bilateral or unilateral upper-motor neuron dysfunction (spasticity, brisk deep tendon reflexes, and Babinski signs) typically manifests in early childhood [<xref ref-type="bibr" rid="tubb4a-leuk.REF.mercimekmahmutoglu.2005.223">Mercimek-Mahmutoglu et al 2005</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.wakusawa.2006.163">Wakusawa et al 2006</xref>].</p>
          <p>Of note, some individuals with a heterozygous <italic toggle="yes">TUBB4A</italic> pathogenic variant and a spastic paraplegia have been described as having mild white matter changes on brain MRI [<xref ref-type="bibr" rid="tubb4a-leuk.REF.kancheva.2015.854">Kancheva et al 2015</xref>], thus expanding the spectrum of <italic toggle="yes">TUBB4A</italic>-related leukodystrophy. To date, however, molecular genetic testing of individuals with as-yet unclassified hereditary spastic paraplegia has not commonly identified a causative heterozygous <italic toggle="yes">TUBB4A</italic> pathogenic variant [<xref ref-type="bibr" rid="tubb4a-leuk.REF.kumar.2015.1857">Kumar et al 2015</xref>].</p>
          <p><bold>Extrapyramidal involvement</bold> due to neostriatal involvement includes rigidity, dystonia, choreoathetosis, oculogyric crisis, and perioral dyskinesia. Extrapyramidal features &#x02013; in particular hemidystonia &#x02013; can be the first manifestation of this condition. Extrapyramidal features can be exacerbated by changes in body position or by visual and acoustic stimuli.</p>
          <p><bold>Gait dysfunction.</bold> Although some individuals achieve independent ambulation, many never do. Gait instability and falls are common.</p>
          <p><bold>Cerebellar signs</bold> can include ataxia, intention tremor, dysmetria, and nystagmus.</p>
          <p><bold>Dysarthria, dysphonia, and swallowing dysfunction.</bold> Communication and feeding difficulties emerge over time, necessitating a gastrostomy tube for feeding in many individuals</p>
          <p><bold>Other less common findings</bold> (seen in severe cases) can include the following [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_der_knaap.2002.1466">van der Knaap et al 2002</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.sasaki.2009.582">Sasaki et al 2009</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al 2013</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.ferreira.2014.1802">Ferreira et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.hamilton.2014.1921">Hamilton et al 2014</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Microcephaly</p>
            </list-item>
            <list-item>
              <p>Short stature</p>
            </list-item>
            <list-item>
              <p>Seizures</p>
            </list-item>
            <list-item>
              <p>Poor vision</p>
            </list-item>
            <list-item>
              <p>Hearing loss</p>
            </list-item>
            <list-item>
              <p>Scoliosis and joint dislocation resulting from a combination of motor dysfunction and improper positioning</p>
            </list-item>
            <list-item>
              <p>Hypogonadotropic hypogonadism (in 1 individual) [<xref ref-type="bibr" rid="tubb4a-leuk.REF.tonduti.2016.323">Tonduti et al 2016</xref>]</p>
            </list-item>
          </list>
          <p><bold>Individuals mosaic for a <italic toggle="yes">TUBB4A</italic> pathogenic variant.</bold> Of note, a few parents of individuals with <italic toggle="yes">TUBB4A</italic>-related hypomyelination have been asymptomatic and mosaic for a <italic toggle="yes">TUBB4A</italic> pathogenic variant [<xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al 2013</xref>].</p>
          <p>
            <bold>Neurophysiologic studies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Electroencephalogram (EEG) is usually normal or demonstrates slow background activity.</p>
            </list-item>
            <list-item>
              <p>Electromyogram (EMG) and nerve conduction studies (NCS) are normal.</p>
            </list-item>
            <list-item>
              <p>Brain stem evoked potentials (BSEP) are usually delayed.</p>
            </list-item>
            <list-item>
              <p>Visual evoked potentials (VEP) are usually normal.</p>
            </list-item>
            <list-item>
              <p>Somatosensory evoked potentials (SEP) in some instances show delayed conduction [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_der_knaap.2002.1466">van der Knaap et al 2002</xref>].</p>
            </list-item>
          </list>
          <p><bold>Laboratory findings.</bold> Cerebrospinal fluid (CSF) analysis is typically normal [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_der_knaap.2002.1466">van der Knaap et al 2002</xref>]. Of note, in some individuals a low level of CSF 5-methyltetrahydrofolic acid was observed with normal plasma folate levels and normal CSF 5-MTHF reductase or decreased CSF homovanillic acid [<xref ref-type="bibr" rid="tubb4a-leuk.REF.tom_svila.2014.161">Tom&#x000e1;s-Vila et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.tonduti.2016.323">Tonduti et al 2016</xref>]; this has not been broadly described [<xref ref-type="bibr" rid="tubb4a-leuk.REF.mercimekmahmutoglu.2007.95">Mercimek-Mahmutoglu &#x00026; Stockler-Ipsiroglu 2007</xref>] and thus is not thought to be a primary metabolic defect.</p>
        </sec>
        <sec id="tubb4a-leuk.GenotypePhenotype_Correlatio">
          <title>Genotype-Phenotype Correlations</title>
          <p>Four <italic toggle="yes">TUBB4A</italic> pathogenic variants are consistently associated with specific phenotypes:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="table" rid="tubb4a-leuk.T.tubb4a_pathogenic_variants">c.745G&#x0003e;A</xref>. In the initial study of persons with classic H-ABC MRI findings, all had this <italic toggle="yes">TUBB4A</italic> pathogenic variant [<xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al 2013</xref>]. Subsequently, individuals with the classic H-ABC phenotype (<xref ref-type="table" rid="tubb4a-leuk.T.tubb4a_pathogenic_variants">Table 2</xref>) were found to have this pathogenic variant as well as others [<xref ref-type="bibr" rid="tubb4a-leuk.REF.hamilton.2015.e371">Hamilton et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="tubb4a-leuk.T.tubb4a_pathogenic_variants">c.730G&#x0003e;A</xref>. Individuals with this pathogenic variant have a typical H-ABC phenotype, but with more severe lack of myelin and a more rapidly progressive disease course [<xref ref-type="bibr" rid="tubb4a-leuk.REF.carvalho.2015.e327">Carvalho et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="table" rid="tubb4a-leuk.T.tubb4a_pathogenic_variants">c.785G&#x0003e;A</xref> and <xref ref-type="table" rid="tubb4a-leuk.T.tubb4a_pathogenic_variants">c.1228G&#x0003e;A</xref>. These pathogenic variants have been described in several individuals with hypomyelination without atrophy of the basal ganglia [<xref ref-type="bibr" rid="tubb4a-leuk.REF.ferreira.2014.1802">Ferreira et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.hamilton.2014.1921">Hamilton et al 2014</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.miyatake.2014.2230">Miyatake et al 2014</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="tubb4a-leuk.Penetrance">
          <title>Penetrance</title>
          <p>The penetrance is not known but appears to be 100%.</p>
          <p>Of note, a few parents of individuals with <italic toggle="yes">TUBB4A</italic>-related hypomyelination have been asymptomatic and mosaic for a <italic toggle="yes">TUBB4A</italic> pathogenic variant [<xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al 2013</xref>].</p>
        </sec>
        <sec id="tubb4a-leuk.Prevalence">
          <title>Prevalence</title>
          <p>The exact prevalence is unknown; 71 affected individuals have been reported to date.</p>
        </sec>
      </sec>
      <sec id="tubb4a-leuk.Genetically_Related_Allelic">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>In addition to the leukodystrophies caused by a heterozygous <italic toggle="yes">TUBB4A</italic> pathogenic variant described in this <italic toggle="yes">GeneReview</italic>, the <italic toggle="yes">TUBB4A</italic> pathogenic variant <xref ref-type="table" rid="tubb4a-leuk.T.tubb4a_pathogenic_variants">c.4C&#x0003e;G</xref> causes the adult-onset disorder laryngeal dysphonia or whispering dysphonia (also known as DYT4 dystonia), in which brain MRI is normal. Affected individuals develop generalized dystonia and ataxic gait later in the disease course [<xref ref-type="bibr" rid="tubb4a-leuk.REF.hersheson.2013.546">Hersheson et al 2013</xref>]. Swallowing difficulty is sometimes observed.</p>
        <p>While Erro et al have hypothesized that the two <italic toggle="yes">TUBB4A</italic>-related leukodystrophy phenotypes (H-ABC and isolated hypomyelination) and DYT4 represent a spectrum of <italic toggle="yes">TUBB4A</italic>-related disorders, DYT4 dystonia differs from the leukodystrophies in that a positive family history with autosomal dominant inheritance is typical [<xref ref-type="bibr" rid="tubb4a-leuk.REF.erro.2015a.828">Erro et al 2015a</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.erro.2015b.e370">Erro et al 2015b</xref>].</p>
      </sec>
      <sec id="tubb4a-leuk.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Hypomyelinating leukodystrophies with early childhood onset and/or extrapyramidal signs should be considered in the differential diagnosis. See <related-object link-type="booklink" source-id="gene" document-id="leukodys-ov" document-type="chapter">Leukodystrophy Overview</related-object>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="pmd" document-type="chapter"><bold>Pelizaeus-Merzbacher disease</bold></related-object>
<bold>(PMD)</bold> is an X-linked disorder caused by a <italic toggle="yes">PLP1</italic> intragenic pathogenic variant or a large <italic toggle="yes">PLP1</italic> deletion/duplication. It typically presents during infancy or early childhood with a combination of nystagmus, upper motor neuron dysfunction, gait ataxia, and extrapyramidal signs. Brain MRI shows diffuse hypomyelination but lacks the classic atrophy of the cerebellum and basal ganglia of a <italic toggle="yes">TUBB4A</italic>-related leukodystrophy, hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC).</p>
        <p><bold>Pelizaeus-Merzbacher like disease (PMLD1;</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608804">OMIM</ext-link><bold>)</bold> is an autosomal recessive disorder caused by biallelic <italic toggle="yes">GJC2</italic> pathogenic variants<italic toggle="yes">.</italic> PMLD1 usually presents during early childhood with manifestations similar to those of the H-ABC phenotype including: developmental delay, speech delay, pyramidal and extrapyramidal involvement, cerebellar signs, and preservation of mental functions. Much like those with PMD, affected children manifest nystagmus early in the disease course [<xref ref-type="bibr" rid="tubb4a-leuk.REF.uhlenberg.2004.251">Uhlenberg et al 2004</xref>] which &#x02013; although it is described in <italic toggle="yes">TUBB4A</italic>-related leukodystrophy &#x02013; is not typical.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="pol3-leuk" document-type="chapter"><bold>Pol III-related leukodystrophies</bold></related-object> are autosomal recessive disorders caused by biallelic pathogenic variants in one of three genes (<italic toggle="yes">POLR3A</italic>, <italic toggle="yes">POLR3B</italic>, or <italic toggle="yes">POLR1C)</italic>. Manifestations include spasticity, gait ataxia, extrapyramidal movement disorders, and cerebellar signs, similar to those of <italic toggle="yes">TUBB4A</italic>-related leukodystrophy. Other manifestations of Pol III-related leukodystrophies include abnormal dentition and hypogonadotropic hypogonadism, which are not commonly associated with <italic toggle="yes">TUBB4A</italic>-related leukodystrophy.</p>
        <p><bold><italic toggle="yes">SOX 10</italic>-associated leukodystrophy/peripheral and central demyelination, Waardenburg syndrome, and Hirschsprung disease (PCWH;</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/609136">OMIM</ext-link><bold>)</bold> is an autosomal dominant disorder caused by heterozygous pathogenic variants in <italic toggle="yes">SOX10</italic>. Manifestations overlap with <italic toggle="yes">TUBB4A</italic>-related leukodystrophy, including developmental delay, spasticity, gait ataxia, and extrapyramidal movement disorders. Additional manifestations of PCWH include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Involvement of the peripheral nervous system (sensory loss)</p>
          </list-item>
          <list-item>
            <p>Waardenburg syndrome (skin and hair pigmentation changes, heterochromia iridis, and hearing loss) and Hirschsprung disease [<xref ref-type="bibr" rid="tubb4a-leuk.REF.inoue.2002.836">Inoue et al 2002</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.bondurand.2007.1169">Bondurand et al 2007</xref>].</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="issd" document-type="chapter"><bold>Free sialic acid storage disorders</bold></related-object> are autosomal recessive neurodegenerative disorders caused by biallelic pathogenic variants in <italic toggle="yes">SLC17A5</italic> that result in defective sialic acid storage and transport. Whereas the most severe form (infantile free sialic acid storage disease) includes coarse facial features and non-neurologic manifestations such as hepatosplenomegaly and cardiomegaly, the milder form (Salla disease) is similar to H-ABC and includes progressive neurologic deterioration with spasticity, extrapyramidal movement disorders, and seizures.</p>
      </sec>
      <sec id="tubb4a-leuk.Management">
        <title>Management</title>
        <sec id="tubb4a-leuk.Evaluations_Following_Initia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">TUBB4A</italic>-related leukodystrophy, the following evaluations are recommended [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_haren.2015.516">Van Haren et al 2015</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation by a pediatric neurologist for evidence of developmental delay, spasticity, and extrapyramidal movement disorders</p>
            </list-item>
            <list-item>
              <p>Assessment of developmental milestones and cognitive function</p>
            </list-item>
            <list-item>
              <p>Assessment of functional disability and equipment needs by a physiotherapist</p>
            </list-item>
            <list-item>
              <p>Assessment of speech (communication) and feeding (swallowing)</p>
            </list-item>
            <list-item>
              <p>Audiologic assessment</p>
            </list-item>
            <list-item>
              <p>Orthopedic evaluation for evidence of scoliosis and/or joint deformity, particularly in individuals with significant dystonia</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="tubb4a-leuk.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Although there is no curative treatment for <italic toggle="yes">TUBB4A</italic>-related leukodystrophies, quality of life can be improved in the following ways.</p>
          <list list-type="bullet">
            <list-item>
              <p>Spasticity that is functionally disabling can lead to joint contractures and scoliosis; both require physical therapy (stretching and positioning) and medical management. Oral GABA agonists such as baclofen and diazepam can be used. In some instances intrathecal baclofen pumps can be considered. For focal spasticity, intramuscular botulinum toxin may be helpful.</p>
            </list-item>
            <list-item>
              <p>Dystonia can be managed with:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Baclofen or intramuscular botulinum toxin when associated with spasticity;</p>
                </list-item>
                <list-item>
                  <p>Trihexyphenidyl or tetrabenazine;</p>
                </list-item>
                <list-item>
                  <p>High doses of levodopa and carbidopa [<xref ref-type="bibr" rid="tubb4a-leuk.REF.wakusawa.2006.163">Wakusawa et al 2006</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.tonduti.2016.323">Tonduti et al 2016</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>When dystonia is refractory to medical management, a baclofen pump may be considered. Of note, to date deep brain stimulation has not been studied in <italic toggle="yes">TUBB4A</italic>-related leukodystrophy.</p>
            </list-item>
            <list-item>
              <p>Swallowing dysfunction may result in use of a gastrostomy for feeding to reduce the risk of aspiration.</p>
            </list-item>
            <list-item>
              <p>Dysarthria may warrant augmentative communication tools.</p>
            </list-item>
            <list-item>
              <p>Anticonvulsant medications should be used when seizures are present.</p>
            </list-item>
            <list-item>
              <p>Constipation, commonly due to neurologic dysfunction and poor intestinal motility, can be treated with diet, laxatives, and stool softeners.</p>
            </list-item>
            <list-item>
              <p>Gastroesophageal reflux disease is common and should be considered in the evaluation of pain.</p>
            </list-item>
            <list-item>
              <p>Functional ability can be improved by use of walkers or wheeled mobility devices and other necessary equipment.</p>
            </list-item>
            <list-item>
              <p>Accommodations in school such as an individual educational plan are often needed. With such accommodations many children with the classic H-ABC phenotype perform at or near grade level for many years, although cognitive decline may be seen later.</p>
            </list-item>
            <list-item>
              <p>Family support and advocacy groups can provide needed psychosocial support for affected individuals.</p>
            </list-item>
          </list>
        </sec>
        <sec id="tubb4a-leuk.Prevention_of_Secondary_Comp">
          <title>Prevention of Secondary Complications</title>
          <p>The following recommendations &#x02013; based on consensus &#x02013; have been developed for all leukodystrophies [<xref ref-type="bibr" rid="tubb4a-leuk.REF.van_haren.2015.516">Van Haren et al 2015</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Calcium and vitamin D supplementation as required to prevent osteoporosis</p>
            </list-item>
            <list-item>
              <p>Skin care and frequent repositioning to help prevent pressure sores in individuals with decreased mobility</p>
            </list-item>
            <list-item>
              <p>Annual flu vaccination</p>
            </list-item>
            <list-item>
              <p>Fall prevention strategies, adaptive equipment (e.g., wheelchairs and walkers), and physical therapy (to increase strength) to help prevent secondary injury</p>
            </list-item>
          </list>
        </sec>
        <sec id="tubb4a-leuk.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Routine evaluations of swallowing and feeding to reduce the risk of aspiration, and nutrition to prevent malnutrition</p>
            </list-item>
            <list-item>
              <p>At least yearly:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Medical evaluation including physical examination to assess weight and medications</p>
                </list-item>
                <list-item>
                  <p>Evaluations by specialists in occupational therapy, physical therapy, speech therapy, and rehabilitation medicine</p>
                </list-item>
                <list-item>
                  <p>Evaluation by orthopedists to assess for scoliosis and joint dislocation</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Annual neurologic evaluation to assess symptoms and any emerging complications</p>
            </list-item>
          </list>
        </sec>
        <sec id="tubb4a-leuk.Evaluation_of_Relatives_at_R">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="tubb4a-leuk.Related_Genetic_Counseling_I">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="tubb4a-leuk.Therapies_Under_Investigatio">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="tubb4a-leuk.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="tubb4a-leuk.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">TUBB4A</italic>-related leukodystrophy is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="tubb4a-leuk.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most probands with <italic toggle="yes">TUBB4A</italic>-related leukodystrophy have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">TUBB4A</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or mosaicism in a parent [<xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p>If the parent is the individual in whom the <italic toggle="yes">TUBB4A</italic> pathogenic variant first occurred, he or she may have germline mosaicism or somatic and germline mosaicism for the variant and be asymptomatic [<xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al 2013</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>Because <italic toggle="yes">TUBB4A</italic>-related leukodystrophy has occurred as the result of a <italic toggle="yes">de novo</italic> pathogenic variant in most cases reported to date, the risk to the sibs of a proband is presumed to be low but greater than that of the general population because of the possibility of germline mosaicism or somatic and germline mosaicism in a parent.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Sib recurrence was reported in a family in which the asymptomatic mother was found to be mosaic for a <italic toggle="yes">TUBB4A</italic> pathogenic variant [<xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al 2013</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">TUBB4A</italic>-related leukodystrophy would have a 50% chance of inheriting the <italic toggle="yes">TUBB4A</italic> pathogenic variant; however, individuals with <italic toggle="yes">TUBB4A</italic>-related leukodystrophy are not known to reproduce.</p>
          <p><bold>Other family members.</bold> Given that most probands with <italic toggle="yes">TUBB4A</italic>-related leukodystrophy reported to date have the disorder as a result of a <italic toggle="yes">de novo TUBB4A</italic> pathogenic variant, the risk to other family members is presumed to be low.</p>
        </sec>
        <sec id="tubb4a-leuk.Related_Genetic_Counseling_I">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to parents of affected individuals.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="tubb4a-leuk.Prenatal_Testing_and_Preimpl">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TUBB4A</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </sec>
      <sec id="tubb4a-leuk.Resources">
        <title>Resources</title>
      </sec>
      <sec id="tubb4a-leuk.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> Alternate splicing results in multiple transcript variants that encode different isoforms (see <related-object source-id="gene" document-id="tubb4a-leuk" object-id="tubb4a-leuk.molgen.TA">Table A</related-object>, <bold>Gene</bold> for details). The transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006087.3">NM_006087.3</ext-link> is 2583 bp and comprises four exons [<xref ref-type="bibr" rid="tubb4a-leuk.REF.lee.1984.5823">Lee et al 1984</xref>].</p>
        <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="tubb4a-leuk.T.tubb4a_pathogenic_variants">Table 2</xref> and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="tubb4a-leuk-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf) for a listing of pathogenic allelic variants.</p>
        <p>Variant c.745G&#x0003e;A is the most common <italic toggle="yes">TUBB4A</italic> pathogenic variant; it is consistently associated with the classic phenotype of hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC).</p>
        <p>Variant c.4C&#x0003e;G is not associated with a leukodystrophy but with DYT4 ("hereditary whispering dysphonia") [<xref ref-type="bibr" rid="tubb4a-leuk.REF.hersheson.2013.546">Hersheson et al 2013</xref>].</p>
        <table-wrap id="tubb4a-leuk.T.tubb4a_pathogenic_variants" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">TUBB4A</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4C&#x0003e;G&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg2Gly</td>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006087.3">NM_006087.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006078.2">NP_006078.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.730G&#x0003e;A&#x000a0;<sup>2,&#x000a0;3</sup></td>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly244Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.745G&#x0003e;A&#x000a0;<sup>2,&#x000a0;3,&#x000a0;4,&#x000a0;5,&#x000a0;6</sup></td>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp249Asn</td>
              </tr>
              <tr>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.785G&#x0003e;A&#x000a0;<sup>2,&#x000a0;3,&#x000a0;4</sup></td>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg262His</td>
              </tr>
              <tr>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1228G&#x0003e;A&#x000a0;<sup>2,&#x000a0;4</sup></td>
                <td headers="hd_h_tubb4a-leuk.T.tubb4a_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu410Lys</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="tubb4a-leuk.TF.2.1">
              <label>1. </label>
              <p>
                <xref ref-type="bibr" rid="tubb4a-leuk.REF.hersheson.2013.546">Hersheson et al [2013]</xref>
              </p>
            </fn>
            <fn id="tubb4a-leuk.TF.2.2">
              <label>2. </label>
              <p>See <xref ref-type="sec" rid="tubb4a-leuk.GenotypePhenotype_Correlatio">Genotype-Phenotype Correlations</xref>.</p>
            </fn>
            <fn id="tubb4a-leuk.TF.2.3">
              <label>3. </label>
              <p>
                <xref ref-type="bibr" rid="tubb4a-leuk.REF.hamilton.2014.1921">Hamilton et al [2014]</xref>
              </p>
            </fn>
            <fn id="tubb4a-leuk.TF.2.4">
              <label>4. </label>
              <p>
                <xref ref-type="bibr" rid="tubb4a-leuk.REF.miyatake.2014.2230">Miyatake et al [2014]</xref>
              </p>
            </fn>
            <fn id="tubb4a-leuk.TF.2.5">
              <label>5. </label>
              <p>
                <xref ref-type="bibr" rid="tubb4a-leuk.REF.ferreira.2014.1802">Ferreira et al [2014]</xref>
              </p>
            </fn>
            <fn id="tubb4a-leuk.TF.2.6">
              <label>6. </label>
              <p>
                <xref ref-type="bibr" rid="tubb4a-leuk.REF.simons.2013.767">Simons et al [2013]</xref>
              </p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>To view information on additional variants, see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="tubb4a-leuk-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold> The transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006087.3">NM_006087.3</ext-link> encodes a &#x003b2;-tubulin protein isoform of 444 amino acids. &#x003b2;-tubulin proteins can bind to &#x003b1;-tubulins to form heterodimers, which form copolymers that assemble into microtubules. Microtubules are an essential component of the cytoskeleton and play important roles in many cellular processes such as mitosis, motility, and transport.</p>
        <p>TUBB4A is predominantly expressed in the CNS, especially in the cerebellum and putamen and white matter [<xref ref-type="bibr" rid="tubb4a-leuk.REF.hersheson.2013.546">Hersheson et al 2013</xref>, <xref ref-type="bibr" rid="tubb4a-leuk.REF.nogales.2001.397">Nogales 2001</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">TUBB4A</italic> result in changes in &#x003b2;-tubulin structure that are thought to affect microtubule polymerization or stability [<xref ref-type="bibr" rid="tubb4a-leuk.REF.savage.1994.2165">Savage et al 1994</xref>].</p>
      </sec>
      <sec id="tubb4a-leuk.References">
        <title>References</title>
        <sec id="tubb4a-leuk.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="tubb4a-leuk.Literature_Cited.reflist0">
            <ref id="tubb4a-leuk.REF.blumkin.2014.107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blumkin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halevy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Ami-Raichman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahari</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haviv</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarit</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leshinsky-Silver</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Expansion of the spectrum of TUBB4A-related disorders: a new phenotype associated with a novel mutation in the TUBB4A gene.</article-title>
                <source>Neurogenetics.</source>
                <year>2014</year>
                <volume>15</volume>
                <fpage>107</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">24526230</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.bondurand.2007.1169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bondurand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastot-Le Moal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanchina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collot</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baral</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giurgea</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skopinski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echaieb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lackmy-Port-Lis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touraine</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V.</given-names>
                  </name>
                </person-group>
                <article-title>Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2007</year>
                <volume>81</volume>
                <fpage>1169</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">17999358</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.carvalho.2015.e327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marques</surname>
                    <given-names>FP</given-names>
                  </name>
                </person-group>
                <article-title>TUBB4A novel mutation reinforces the genotype-phenotype correlation of hypomyelination with atrophy of the basal ganglia and cerebellum.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e327</fpage>
                <pub-id pub-id-type="pmid">25168210</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.erro.2015a.828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hersheson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ganos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mencacci</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stamelou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Batla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thust</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bras</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerreiro</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinn</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <article-title>H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?</article-title>
                <source>Mov Disord.</source>
                <year>2015a</year>
                <volume>30</volume>
                <fpage>828</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">25545912</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.erro.2015b.e370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hersheson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <article-title>A novel TUBB4A mutation suggests that genotype-phenotype correlation of H-ABC syndrome needs to be revisited.</article-title>
                <source>Brain.</source>
                <year>2015b</year>
                <volume>138</volume>
                <fpage>e370</fpage>
                <pub-id pub-id-type="pmid">25614026</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.ferreira.2014.1802">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poretti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamosh</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC).</article-title>
                <source>Am J Med Genet A.</source>
                <year>2014</year>
                <volume>164A</volume>
                <fpage>1802</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24706558</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.hamilton.2014.1921">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragu&#x0017e;</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumkin</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>H-ABC Research Group, van Berkel CG, Waisfisz Q, Simons C, Taft RJ, Abbink TE, Wolf NI, van der Knaap MS. Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlation.</article-title>
                <source>Brain.</source>
                <year>2014</year>
                <volume>137</volume>
                <fpage>1921</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">24785942</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.hamilton.2015.e371">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Reply: A novel TUBB4A mutation suggests that genotype-phenotype correlation of H-ABC syndrome needs to be revisited.</article-title>
                <source>Brain.</source>
                <year>2015</year>
                <volume>138</volume>
                <fpage>e371</fpage>
                <pub-id pub-id-type="pmid">25619510</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.hersheson.2013.546">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hersheson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mencacci</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trabzuni</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryten</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pittman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paudel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kara</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fawcett</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plagnol</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medlar</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanescu</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the autoregulatory domain of &#x003b2;-tubulin 4a cause hereditary dystonia.</article-title>
                <source>Ann Neurol.</source>
                <year>2013</year>
                <volume>73</volume>
                <fpage>546</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">23424103</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.inoue.2002.836">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shilo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boerkoel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crowe</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawady</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agamanolis</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <article-title>Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease: phenotypes linked by SOX10 mutation.</article-title>
                <source>Ann Neurol.</source>
                <year>2002</year>
                <volume>52</volume>
                <fpage>836</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12447940</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.kancheva.2015.854">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kancheva</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chamova</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitev</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azmanov</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalaydjieva</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Mosaic dominant TUBB4A mutation in an inbred family with complicated hereditary spastic paraplegia.</article-title>
                <source>Mov Disord.</source>
                <year>2015</year>
                <volume>30</volume>
                <fpage>854</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25772097</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.kumar.2015.1857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vulinovic</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaake</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in TUBB4A and spastic paraplegia.</article-title>
                <source>Mov Disord.</source>
                <year>2015</year>
                <volume>30</volume>
                <fpage>1857</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">26477786</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.lee.1984.5823">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loomis</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowan</surname>
                    <given-names>NJ</given-names>
                  </name>
                </person-group>
                <article-title>Sequence of an expressed human beta-tubulin gene containing ten Alu family members.</article-title>
                <source>Nucleic Acids Res.</source>
                <year>1984</year>
                <volume>12</volume>
                <fpage>5823</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">6462917</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.mercimekmahmutoglu.2007.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mercimek-Mahmutoglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockler-Ipsiroglu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.</article-title>
                <source>Tohoku J Exp Med.</source>
                <year>2007</year>
                <volume>211</volume>
                <fpage>95</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17202777</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.mercimekmahmutoglu.2005.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mercimek-Mahmutoglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baric</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prayer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoeckler-Ipsiroglu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC). Report of a new case.</article-title>
                <source>Neuropediatrics.</source>
                <year>2005</year>
                <volume>36</volume>
                <fpage>223</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15944912</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.miyatake.2014.2230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyatake</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morimoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ando</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikuta</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakashima</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsurusaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>Expanding the phenotypic spectrum of TUBB4A-associated hypomyelinating leukoencephalopathies.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>82</volume>
                <fpage>2230</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">24850488</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.nogales.2001.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nogales</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>Structural insight into microtubule function.</article-title>
                <source>Annu Rev Biophys Biomol Struct.</source>
                <year>2001</year>
                <volume>30</volume>
                <fpage>397</fpage>
                <lpage>420</lpage>
                <pub-id pub-id-type="pmid">11441808</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.pizzino.2014.898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pizzino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrero</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Padiath</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakonarson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funari</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taft</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>TUBB4A de novo mutations cause isolated hypomyelination.</article-title>
                <source>Neurology.</source>
                <year>2014</year>
                <volume>83</volume>
                <fpage>898</fpage>
                <lpage>902</lpage>
                <pub-id pub-id-type="pmid">25085639</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.purnell.2014.608">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Purnell</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bleyl</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonkowsky</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Clinical exome sequencing identifies a novel TUBB4A mutation in a child with static hypomyelinating leukodystrophy.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2014</year>
                <volume>50</volume>
                <fpage>608</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">24742798</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.sagnelli.2016.591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sagnelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiapparini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marotta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonduti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Consonni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scigliuolo</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benti</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taroni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salsano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Bella</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Early-onset progressive spastic paraplegia caused by a novel TUBB4A mutation: brain MRI and FDG-PET findings.</article-title>
                <source>J Neurol.</source>
                <year>2016</year>
                <volume>263</volume>
                <fpage>591</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">26810722</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.sasaki.2009.582">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakuma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furushima</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum.</article-title>
                <source>Brain Dev.</source>
                <year>2009</year>
                <volume>31</volume>
                <fpage>582</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18851904</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.savage.1994.2165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zakhary</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chalfie</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the Caenorhabditis elegans beta-tubulin gene mec-7: effects on microtubule assembly and stability and on tubulin autoregulation.</article-title>
                <source>J Cell Sci.</source>
                <year>1994</year>
                <volume>107</volume>
                <fpage>2165</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">7983175</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.shimojima.2015.281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimojima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okumura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher disease.</article-title>
                <source>Brain Dev.</source>
                <year>2015</year>
                <volume>37</volume>
                <fpage>281</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24974158</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.simons.2013.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNeil</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldovic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devaney</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanohashi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crawford</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ru</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimmond</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonduti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chudnow</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Coster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kisler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taft</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A de novo mutation in the &#x003b2;-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2013</year>
                <volume>92</volume>
                <fpage>767</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">23582646</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.tom_svila.2014.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tom&#x000e1;s-Vila</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menor</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ley-Martos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jumillas-Luj&#x000e1;n</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marco-Hern&#x000e1;ndez</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbero</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity</article-title>
                <source>Rev Neurol.</source>
                <year>2014</year>
                <volume>58</volume>
                <fpage>161</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24504878</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.tonduti.2016.323">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tonduti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aiello</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renaldo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorboz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saaman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fettah</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmaleh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancheri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barresi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boccone</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orcesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pichiecchio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zangaglia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurey</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>TUBB4A-related hypomyelinating leukodystrophy: New insights from a series of 12 patients.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>2016</year>
                <volume>20</volume>
                <fpage>323</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">26643067</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.uhlenberg.2004.251">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Uhlenberg</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuelke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000fc;schendorf</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruf</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaindl</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henneke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoltenburg-Didinger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000fc;bner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weschke</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2004</year>
                <volume>75</volume>
                <fpage>251</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15192806</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.van_der_knaap.2002.1466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouwels</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonavita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Coster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surtees</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>2002</year>
                <volume>23</volume>
                <fpage>1466</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">12372733</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.van_haren.2015.516">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Haren</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonkowsky</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suhr</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waggoner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanderver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patterson</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>GLIA Consortium. Consensus statement on preventive and symptomatic care of leukodystrophy patients.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2015</year>
                <volume>114</volume>
                <fpage>516</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">25577286</pub-id>
              </element-citation>
            </ref>
            <ref id="tubb4a-leuk.REF.wakusawa.2006.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wakusawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Togashi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishitobi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onuma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iinuma</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.</article-title>
                <source>Tohoku J Exp Med.</source>
                <year>2006</year>
                <volume>209</volume>
                <fpage>163</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16707859</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="tubb4a-leuk.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="tubb4a-leuk.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>3 November 2016 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>2 January 2016 (av) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="tubb4a-leuk.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>MRI findingsA. Cerebellar white matter T<sub>1</sub>-weighted signal that is isointense or mildly hyper- or hypointense relative to gray matter structures; cerebellar atrophy prominently affects the vermis. There are no specific signal changes to the brain stem or dentate nucleus that could help differentiate <italic toggle="yes">TUBB4A</italic>-related leukodystrophy from other hypomyelinating leukodystrophies.B. Progressive atrophy of the basal ganglia predominantly involving the neostriatum (i.e., the putamen and caudate nucleus), often with a significant decrease in size of the putamen (thin white arrow) and to a lesser degree the head of the caudate. The thalamus and globus pallidus are typically spared.C. Diffuse cerebral hypomyelination manifesting as mild T<sub>2</sub>-weighted hyperintensity involving the supratentorial white matter (thick white arrow)D. Diffuse cerebral hypomyelination typically manifesting as isointense or mild T<sub>1</sub>-weighted hyperintensity involving the supratentorial white matter (thick white arrow)E. Cerebellar white matter T<sub>1</sub>-weighted signal that is isointense or mildly hyper- or hypointense relative to gray matter structures. Although cerebellar atrophy prominently affecting the vermis is common (dotted line arrow), it is not an obligatory finding.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tubb4a-leuk-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
